Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

WHWKWhitehawk Therapeutics, Inc.

Nasdaq · CIK 0001422142
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts362

Identity from submissions API

NameWhitehawk Therapeutics, Inc.
CIK0001422142
TickersWHWK
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN611547850
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone551-321-2234
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Aadi Bioscience, Inc. (2021-08-27T04:00:00.000Z → 2025-03-18T04:00:00.000Z)
  • Aerpio Pharmaceuticals, Inc. (2017-03-17T04:00:00.000Z → 2021-08-23T04:00:00.000Z)
  • ZETA ACQUISITION CORP II (2008-02-01T05:00:00.000Z → 2017-03-13T04:00:00.000Z)
Business address
2 HEADQUARTERS PLAZA
EAST BUILDING, 11TH FLOOR
MORRISTOWN
NJ
07960
NJ
Mailing address
2 HEADQUARTERS PLAZA
EAST BUILDING, 11TH FLOOR
MORRISTOWN
NJ
07960
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

676 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-052436 005-83932 261561750 34 20036
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001943462-26-000010 005-83932 261556705 34 74543
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127421 005-83932 261554963 34 18543
2026-11-09 10-Q 10-Q 0001193125-26-453576 001-38560 261535940 34 12642216 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-452704 001-38560 261533904 34 642722 1 1
2026-09-18 4/A xslF345X06/form4a-09182026_080953.xml 0001754154-26-000016 9284
2026-09-18 4/A xslF345X06/form4a-09182026_080958.xml 0001766522-26-000017 9245
2026-09-18 4/A xslF345X06/form4a-09182026_080955.xml 0001821353-26-000007 9244
2026-09-18 4/A xslF345X06/form4a-09182026_080949.xml 0001995275-26-000018 9270
2026-09-18 4/A xslF345X06/form4a-09182026_080933.xml 0001909734-26-000011 9278
2026-09-15 4 xslF345X06/form4-09152026_110953.xml 0001995275-26-000016 9242
2026-09-15 4 xslF345X06/form4-09152026_110910.xml 0001754154-26-000014 9256
2026-09-15 4 xslF345X06/form4-09152026_110928.xml 0001909734-26-000009 9250
2026-09-15 4 xslF345X06/form4-09152026_110942.xml 0001821353-26-000005 9216
2026-09-15 4 xslF345X06/form4-09152026_110959.xml 0001766522-26-000015 9217
2026-09-11 4 xslF345X06/form4-09112026_080943.xml 0001670000-26-000008 6282
2026-09-11 3 xslF345X06/form3-09112026_080942.xml 0001670000-26-000007 10254
2026-09-10 8-K 8-K 5.02,9.01 0001193125-26-388010 001-38560 261371867 34 168370 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000947871-26-000805 005-83932 261284079 34 17255
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-038432 005-83932 261282452 34 25557
2026-08-06 10-Q 10-Q 0001193125-26-337933 001-38560 261248783 34 11672680 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-337069 001-38560 261246846 34 629078 1 1
2026-07-30 4 xslF345X06/form4-07302026_080728.xml 0001602474-26-000004 9233
2026-06-15 4 xslF345X06/form4-06152026_090634.xml 0002049287-26-000003 6253
2026-06-15 4 xslF345X06/form4-06152026_090628.xml 0001680329-26-000005 6235
2026-06-15 4 xslF345X06/form4-06152026_090617.xml 0001364590-26-000003 6260
2026-06-15 4 xslF345X06/form4-06152026_090619.xml 0001654482-26-000003 6247
2026-06-15 4 xslF345X06/form4-06152026_090610.xml 0001878692-26-000003 6248
2026-06-15 4 xslF345X06/form4-06152026_090621.xml 0001355758-26-000007 6252
2026-06-15 4 xslF345X06/form4-06152026_090652.xml 0001701815-26-000006 10762
2026-06-12 8-K 8-K 5.07 0001193125-26-269493 001-38560 261086988 34 171438 1 1
2026-06-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001932 333-296353 261077895 33 2106
2026-06-05 CORRESP filename1.htm 0001193125-26-259538 7838
2026-06-05 UPLOAD filename1.pdf 0000000000-26-005723 333-296353 151663
2026-05-29 S-3 S-3 0001193125-26-248349 333-296353 261044718 33 573636 1 1
2026-05-21 8-K 8-K 8.01,9.01 0001193125-26-234890 001-38560 261009905 34 171954 1 1
2026-05-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000935836-26-000289 005-83932 26995462 34 23669
2026-05-18 4 xslF345X06/form4-05182026_080531.xml 0001909734-26-000005 5153
2026-05-18 4 xslF345X06/form4-05182026_080529.xml 0001766522-26-000013 5121
2026-05-18 4 xslF345X06/form4-05182026_080534.xml 0001754154-26-000012 5154
2026-05-18 4 xslF345X06/form4-05182026_080535.xml 0001995275-26-000014 5140
2026-05-18 4 xslF345X06/form4-05182026_080536.xml 0001355758-26-000003 9152
2026-05-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000902664-26-002450 005-83932 26981492 34 17991
2026-05-14 4 xslF345X06/ownership.xml 0000902664-26-002449 11816
2026-05-13 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-220656 001-38560 26971012 34 806278 1 1
2026-05-07 10-Q 10-Q 0001193125-26-212075 001-38560 26953941 34 10250722 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210615 001-38560 26951191 34 535880 1 1
2026-04-28 DEFA14A DEFA14A 0001193125-26-187189 001-38560 26908228 34 3247528 1 1
2026-04-28 ARS ARS 0001193125-26-187156 001-38560 26908172 34 4311163
2026-04-28 DEF 14A DEF 14A 0001193125-26-187149 001-38560 26908150 34 13470174 1 1
2026-04-17 4 xslF345X06/form4-04172026_080413.xml 0001754154-26-000010 7145
2026-04-15 144 xsl144X01/primary_doc.xml 0001754154-26-000007 001-38560 26865340 33 5450
2026-04-15 4 xslF345X06/form4-04152026_110455.xml 0001766522-26-000011 6900
2026-04-13 4 xslF345X06/form4-04142026_120420.xml 0001766522-26-000009 6899
2026-04-10 4 xslF345X06/form4-04102026_100459.xml 0001995275-26-000012 5374
2026-04-09 144 xsl144X01/primary_doc.xml 0001766522-26-000007 001-38560 26852921 33 5360
2026-04-09 144 xsl144X01/primary_doc.xml 0001995275-26-000011 001-38560 26852870 33 8246
2026-04-08 4 xslF345X06/form4-04092026_120451.xml 0001995275-26-000008 8396
2026-04-03 4 xslF345X06/form4-04032026_100433.xml 0001821353-26-000003 6376
2026-04-03 4 xslF345X06/form4-04032026_100421.xml 0001909734-26-000003 6410
2026-04-03 4 xslF345X06/form4-04032026_100426.xml 0001766522-26-000005 10569
2026-04-03 4 xslF345X06/form4-04032026_100439.xml 0001754154-26-000005 10568
2026-04-03 4 xslF345X06/form4-04032026_100411.xml 0001995275-26-000006 12256
2026-04-02 144 xsl144X01/primary_doc.xml 0001995275-26-000005 001-38560 26836641 33 5499
2026-03-12 S-8 S-8 0001193125-26-104333 333-294256 26748595 33 236986 1 1
2026-03-12 10-K 10-K 0001193125-26-104158 001-38560 26747838 34 19169014 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-103117 001-38560 26745704 34 612230 1 1
2026-03-10 4 xslF345X05/form4-03102026_110350.xml 0001995275-26-000002 9545
2026-03-10 4 xslF345X05/form4-03102026_110300.xml 0001754154-26-000002 9556
2026-03-10 4 xslF345X05/form4-03102026_110307.xml 0001766522-26-000002 9559
2025-12-02 4 xslF345X05/form4-12022025_091222.xml 0001909734-25-000006 9112
2025-12-02 3 xslF345X02/form3-12022025_091232.xml 0001909734-25-000005 10212
2025-11-06 10-Q 10-Q 0001193125-25-268895 001-38560 251457387 34 12476304 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-268134 001-38560 251456266 34 627074 1 1
2025-08-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003766 005-83932 251251317 34 15892
2025-08-07 10-Q 10-Q 0000950170-25-105081 001-38560 251194507 34 12346250 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-104592 001-38560 251191725 34 621816 1 1
2025-06-17 4 xslF345X05/form4-06182025_120641.xml 0001415889-25-017620 6065
2025-06-17 4 xslF345X05/form4-06172025_080628.xml 0001415889-25-017547 12728
2025-06-16 4 xslF345X05/form4-06162025_080632.xml 0001415889-25-017412 13222
2025-06-16 4 xslF345X05/form4-06162025_080629.xml 0001415889-25-017411 13231
2025-06-16 4 xslF345X05/form4-06162025_080636.xml 0001415889-25-017410 13197
2025-06-16 4 xslF345X05/form4-06162025_080636.xml 0001415889-25-017409 13224
2025-06-16 4 xslF345X05/form4-06162025_080639.xml 0001415889-25-017407 13173
2025-06-16 4 xslF345X05/form4-06162025_080637.xml 0001415889-25-017406 17610
2025-06-13 8-K 8-K 5.07 0001193125-25-140810 001-38560 251047233 34 152716 1 1
2025-05-22 UPLOAD filename1.pdf 0000000000-25-005482 001-38560 40048
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000947871-25-000540 005-83932 25956417 34 15438
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002376 005-83932 25952161 34 12588
2025-05-13 CORRESP filename1.htm 0001193125-25-119011 21173
2025-05-08 10-Q 10-Q 0001628280-25-023932 001-38560 25927539 34 7832375 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001628280-25-023788 001-38560 25926074 34 259546 1 1
2025-05-07 UPLOAD filename1.pdf 0000000000-25-004861 001-38560 42747
2025-04-28 ARS ARS 0001193125-25-100734 001-38560 25881236 34 21550692
2025-04-28 DEFA14A DEFA14A 0001628280-25-020317 001-38560 25880946 34 383165
2025-04-28 DEF 14A DEF 14A 0001628280-25-020311 001-38560 25880909 34 3837772 1 1
2025-04-25 424B5 424B5 0001193125-25-097064 333-277018 25874942 33 387829
2025-04-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001044 333-286284 25823449 33 2105
2025-04-04 CORRESP filename1.htm 0001193125-25-073631 8994
2025-04-04 UPLOAD filename1.pdf 0000000000-25-003667 333-286284 40454
2025-04-03 4 xslF345X05/form4-04032025_110433.xml 0001415889-25-010080 8916
2025-04-03 4 xslF345X05/form4-04032025_110445.xml 0001415889-25-010079 8867
2025-04-03 4 xslF345X05/form4-04032025_110406.xml 0001415889-25-010076 8901
2025-03-31 S-3 S-3 0001193125-25-068942 333-286284 25795271 33 866606
2025-03-31 8-K/A 8-K/A 9.01 0001193125-25-068845 001-38560 25794515 34 242786 1 1
2025-03-28 S-8 S-8 0001193125-25-067200 333-286229 25787293 33 90524
2025-03-28 10-K 10-K 0001628280-25-015269 001-38560 25780795 34 22159589 1 1
2025-03-26 8-K 8-K 2.01,9.01 0001193125-25-063253 001-38560 25770268 34 150223 1 1
2025-03-18 8-K 8-K 2.02,5.03,9.01 0001193125-25-056708 001-38560 25749020 34 531871 1 1
2025-03-18 D xslFormDX01/primary_doc.xml 06b 0002018445-25-000002 021-541194 25746698 33 17422
2025-03-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-001906 005-83932 25729521 34 18960
2025-03-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-009710 005-83932 25724169 34 73131
2025-03-06 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-034969 005-83932 25716647 34 8524
2025-03-05 4 xslF345X05/form4-03062025_120354.xml 0001415889-25-007096 6346
2025-03-05 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000045 005-83932 25710750 34 17202
2025-03-04 4 xslF345X05/form4-03052025_120307.xml 0001415889-25-006742 5851
2025-03-04 4 xslF345X05/form4-03042025_110310.xml 0001415889-25-006682 4994
2025-03-04 4 xslF345X05/form4-03042025_110311.xml 0001415889-25-006678 6111
2025-03-04 4 xslF345X05/form4-03042025_110346.xml 0001415889-25-006676 17507
2025-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-25-001335 005-83932 25707072 34 14847
2025-03-04 4 xslF345X05/ownership.xml 0000902664-25-001334 11391
2025-03-04 8-K 8-K 1.01,5.07,7.01,9.01 0001193125-25-045605 001-38560 25704636 34 462657 1 1
2025-03-03 4 xslF345X05/form4-03042025_010336.xml 0001415889-25-006318 15992
2025-03-03 4 xslF345X05/form4-03042025_010346.xml 0001415889-25-006316 9407
2025-03-03 144 xsl144X01/primary_doc.xml 0001786205-25-000024 001-38560 25701005 33 4676
2025-03-03 144 xsl144X01/primary_doc.xml 0001786205-25-000023 001-38560 25700999 33 4578
2025-03-03 144 xsl144X01/primary_doc.xml 0001786205-25-000022 001-38560 25700987 33 4546
2025-02-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000038 005-83932 25655207 34 17060
2025-02-19 DEFA14A DEFA14A 0001193125-25-029692 001-38560 25641574 34 29866
2025-02-18 3 xslF345X02/form3-02182025_090217.xml 0001415889-25-004450 10060
2025-02-18 DEFA14A DEFA14A 0001193125-25-028632 001-38560 25635237 34 40152
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895345-25-000071 005-83932 25630500 34 6217
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020936 005-83932 25626483 34 7023
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000158 005-83932 25625520 34 16083
2025-02-05 DEFA14A DEFA14A 0001193125-25-020865 001-38560 25594034 34 38089
2025-02-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000005 005-83932 25586116 34 42227
2025-01-31 DEFM14A DEFM14A 0001193125-25-018470 001-38560 25579373 34 10200255
2025-01-30 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000003 005-83932 25573334 34 22382
2025-01-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000547 005-83932 25570638 34 17518
2025-01-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000935836-25-000082 005-83932 25553634 34 24592
2025-01-21 PREM14A PREM14A 0001193125-25-009599 001-38560 25543121 34 9831759
2024-12-31 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-24-000118 005-83932 241591665 34 16540
2024-12-30 DEFA14A DEFA14A 0001193125-24-286907 001-38560 241590488 34 60835
2024-12-23 4 xslF345X05/form4-12232024_101210.xml 0001415889-24-030096 6033
2024-12-23 3 xslF345X02/form3-12232024_101253.xml 0001415889-24-030095 10026
2024-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-24-139724 005-83932 241575000 34 20235
2024-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-24-007000 005-83932 241573403 34 16974
2024-12-20 DEFA14A DEFA14A 0001193125-24-282417 001-38560 241564973 34 4720369
2024-12-20 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001193125-24-282407 001-38560 241564953 34 5175263 1 1
2024-11-06 10-Q 10-Q 0001628280-24-045698 001-38560 241430963 34 7739353 1 1
2024-11-06 8-K 8-K 2.02,9.01 0001628280-24-045465 001-38560 241429309 34 263172 1 1
2024-10-03 4 xslF345X05/form4-10032024_111036.xml 0001415889-24-024676 15664
2024-10-03 144 xsl144X01/primary_doc.xml 0001995275-24-000003 001-38560 241353073 33 297694
2024-10-01 SC 13D/A SC 13D/A 0001193125-24-230376 005-83932 241344574 34 33358
2024-09-30 8-K 8-K 8.01 0001193125-24-228322 001-38560 241336460 34 143145 1 1
2024-09-19 8-K 8-K 5.02,9.01 0001193125-24-222116 001-38560 241310561 34 181946 1 1
2024-09-05 4 xslF345X05/form4-09052024_090938.xml 0001415889-24-022964 6980
2024-09-03 SC 13G aadi.htm 0000935836-24-000579 005-83932 241275295 34 48107
2024-09-03 144 xsl144X01/primary_doc.xml 0001949846-24-000526 001-38560 241272589 33 7623
2024-08-28 SC 13G aadi13g.htm 0001373604-24-000079 005-83932 241256086 34 76706
2024-08-22 8-K 8-K 5.02 0001193125-24-205370 001-38560 241232180 34 144655 1 1
2024-08-21 8-K 8-K 2.05,8.01,9.01 0001193125-24-203889 001-38560 241227010 34 167272 1 1
2024-08-07 10-Q 10-Q 0001628280-24-035636 001-38560 241184035 34 7394570 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001628280-24-035390 001-38560 241181514 34 267771 1 1
2024-08-05 4 xslF345X05/form4-08052024_100800.xml 0001415889-24-020784 10982
2024-07-02 4 xslF345X05/form4-07022024_100754.xml 0001415889-24-019045 8982
2024-06-14 4 xslF345X05/form4-06142024_080636.xml 0001415889-24-016874 10360
2024-06-14 4 xslF345X05/form4-06142024_080605.xml 0001415889-24-016873 5994
2024-06-14 4 xslF345X05/form4-06142024_080614.xml 0001415889-24-016872 5981
2024-06-14 4 xslF345X05/form4-06142024_080619.xml 0001415889-24-016870 5969
2024-06-14 4 xslF345X05/form4-06142024_080632.xml 0001415889-24-016868 5986
2024-06-14 4 xslF345X05/form4-06142024_080626.xml 0001415889-24-016865 5941
2024-06-14 4 xslF345X05/form4-06142024_080653.xml 0001415889-24-016862 5999
2024-06-12 8-K 8-K 5.07 0001628280-24-027826 001-38560 241038638 34 165241 1 1
2024-06-05 4 xslF345X05/form4-06052024_080618.xml 0001415889-24-015561 8982
2024-06-03 144 xsl144X01/primary_doc.xml 0001949846-24-000316 001-38560 241012766 33 6438
2024-05-08 10-Q 10-Q 0001628280-24-021657 001-38560 24925859 34 6959101 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001628280-24-021381 001-38560 24924335 34 254712 1 1
2024-05-03 424B5 424B5 0001193125-24-130684 333-277018 24913009 33 224069
2024-05-01 4 xslF345X05/form4-05022024_120534.xml 0001415889-24-011937 6981
2024-04-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-30 16:00:00 9999999995-24-001211 333-277018 24899795 33 1982
2024-04-26 CORRESP filename1.htm 0001193125-24-118308 7559
2024-04-26 ARS ARS 0001193125-24-118295 001-38560 24884837 34 14263245
2024-04-26 3 xslF345X02/form3-04262024_080448.xml 0001415889-24-011595 16578
2024-04-26 DEFA14A DEFA14A 0001628280-24-018548 001-38560 24882224 34 1257947
2024-04-26 DEF 14A DEF 14A 0001628280-24-018546 001-38560 24882211 34 3601411 1 1
2024-04-04 8-K 8-K 1.01 0001628280-24-014876 001-38560 24823213 34 150102 1 1
2024-04-03 4 xslF345X05/form4-04032024_080413.xml 0001415889-24-010037 8982
2024-03-13 10-K 10-K 0001628280-24-010901 001-38560 24746189 34 12558254 1 1
2024-03-13 8-K 8-K 2.02,9.01 0001628280-24-010791 001-38560 24744637 34 281014 1 1
2024-03-04 4 xslF345X05/form4-03052024_120319.xml 0001415889-24-006421 8983
2024-03-04 4 xslF345X05/form4-03052024_120358.xml 0001415889-24-006416 11331
2024-03-04 4 xslF345X05/form4-03052024_120318.xml 0001415889-24-006414 11497
2024-03-04 4 xslF345X05/form4-03052024_120310.xml 0001415889-24-006411 11463
2024-03-01 144 xsl144X01/primary_doc.xml 0001949846-24-000105 001-38560 24708489 33 99504
2024-02-20 UPLOAD filename1.pdf 0000000000-24-001932 333-277018 40537
2024-02-12 S-8 S-8 0001193125-24-032285 333-277020 24621341 33 96983
2024-02-12 S-3 S-3 0001193125-24-032274 333-277018 24621267 33 636478
2024-02-02 4 FORM 4 SUBMISSION 0001209191-24-002684 7142
2024-01-02 4 FORM 4 SUBMISSION 0001209191-24-000254 7142
2023-12-14 8-K 8-K 8.01,9.01 0001193125-23-295566 001-38560 231487866 34 2458770 1 1
2023-12-07 4 FORM 4 SUBMISSION 0001209191-23-057713 7059
2023-12-05 4 FORM 4 SUBMISSION 0001209191-23-057545 11387
2023-12-01 144 xsl144X01/primary_doc.xml 0001949846-23-000458 001-38560 231458120 33 8163
2023-11-08 10-Q 10-Q 0001628280-23-037905 001-38560 231388962 34 7292126 1 1
2023-11-08 8-K/A 8-K/A 2.02,9.01 0001628280-23-037882 001-38560 231388317 34 283592 1 1
2023-11-08 8-K 8-K 2.02,9.01 0001628280-23-037568 001-38560 231386046 34 166992 1 1
2023-11-02 4 FORM 4 SUBMISSION 0001209191-23-054214 9225
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051697 9224
2023-10-03 4 FORM 4 SUBMISSION 0001209191-23-051695 8793
2023-10-03 3 FORM 3 SUBMISSION 0001209191-23-051694 5355
2023-10-02 8-K 8-K 5.02,7.01,9.01 0001193125-23-248461 001-38560 231298013 34 553786 1 1
2023-09-06 4 FORM 4 SUBMISSION 0001209191-23-048535 11385
2023-09-01 144 xsl144X01/primary_doc.xml 0001949846-23-000307 001-38560 231231344 33 8760
2023-08-09 10-Q 10-Q 0001628280-23-028562 001-38560 231155133 34 7034935 1 1
2023-08-09 8-K 8-K 2.02,9.01 0001628280-23-028411 001-38560 231153441 34 287509 1 1
2023-08-03 4 FORM 4 SUBMISSION 0001209191-23-044439 9222
2023-07-06 4 FORM 4 SUBMISSION 0001209191-23-041700 11389
2023-07-03 144 xsl144X01/primary_doc.xml 0001949846-23-000177 001-38560 231064133 33 213549
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038675 10150
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038665 5913
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038664 5921
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038663 5896
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038662 5868
2023-06-20 4 FORM 4 SUBMISSION 0001209191-23-038661 5926
2023-06-16 8-K 8-K 5.07 0001628280-23-022421 001-38560 231020663 34 195111 1 1
2023-06-06 4 FORM 4 SUBMISSION 0001209191-23-034888 7058
2023-06-05 4 FORM 4 SUBMISSION 0001209191-23-034632 11384
2023-05-10 10-Q 10-Q 0001628280-23-017234 001-38560 23906551 34 7054669 1 1
2023-05-10 8-K 8-K 2.02,9.01 0001628280-23-017031 001-38560 23904425 34 288829 1 1
2023-05-05 4 FORM 4 SUBMISSION 0001209191-23-027672 7058
2023-05-03 4 FORM 4 SUBMISSION 0001209191-23-027161 11383
2023-04-28 ARS ARS 0001193125-23-125869 001-38560 23863464 34 8946420
2023-04-28 DEFA14A DEFA14A 0001628280-23-014004 001-38560 23863054 34 619436
2023-04-28 DEF 14A DEF 14A 0001628280-23-014000 001-38560 23863003 34 3938846 1 1
2023-04-06 4 FORM 4 SUBMISSION 0001209191-23-023692 7060
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023483 11380
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-022657 6226
2023-04-03 144 xsl144X01/primary_doc.xml 0001949846-23-000022 001-38560 23791851 33 4484
2023-03-29 4 FORM 4 SUBMISSION 0001209191-23-021531 5979
2023-03-29 3 FORM 3 SUBMISSION 0001209191-23-021530 5286
2023-03-29 S-8 S-8 0001193125-23-083652 333-270933 23775252 33 88816
2023-03-29 10-K 10-K 0001628280-23-009583 001-38560 23770824 34 32045386 1 1
2023-03-28 8-K/A 8-K/A 5.02 0001193125-23-082149 001-38560 23769569 34 149470 1 1
2023-03-28 8-K 8-K 2.02,5.02,9.01 0001628280-23-009345 001-38560 23766272 34 340781 1 1
2023-03-03 8-K 8-K 5.02,7.01,9.01 0001193125-23-059077 001-38560 23701740 34 179576 1 1
2023-03-02 4 FORM 4 SUBMISSION 0001209191-23-014615 6057
2023-03-02 4 FORM 4 SUBMISSION 0001209191-23-014603 6183
2023-03-02 4 FORM 4 SUBMISSION 0001209191-23-014589 6188
2023-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-23-010884 005-83932 23620328 34 74467
2023-02-10 SC 13G/A ff1723252_13ga1-satter.htm 0000895345-23-000071 005-83932 23610067 34 59916
2023-01-23 8-K 8-K 1.01 0001193125-23-012507 001-38560 23542460 34 145238 1 1
2023-01-17 SC 13D/A SC 13D/A 0001193125-23-009518 005-83932 23532095 34 50857
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-000857 6190
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-000843 6203
2022-12-07 8-K 8-K 5.03,9.01 0001193125-22-300219 001-38560 221450792 34 367746 1 1
2022-11-28 8-K 8-K 3.01 0001193125-22-292703 001-38560 221420955 34 146119 1 1
2022-11-09 10-Q 10-Q 0001628280-22-029228 001-38560 221372695 34 7828002 1 1
2022-11-09 8-K 8-K 2.02,5.02,9.01 0001193125-22-280757 001-38560 221370762 34 296169 1 1
2022-11-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-04 16:00:00 9999999995-22-003214 333-268021 221363523 33 1934
2022-11-04 424B3 424B3 0001193125-22-277880 333-268021 221362311 33 175052
2022-11-02 CORRESP filename1.htm 0001193125-22-275811 8139
2022-11-01 UPLOAD filename1.pdf 0000000000-22-011922 40403
2022-10-26 S-3 S-3 0001193125-22-269638 333-268021 221333814 33 301205
2022-10-11 D xslFormDX01/primary_doc.xml 06b 0001209191-22-053234 021-461325 221303300 33 13980
2022-10-04 SC 13G ff1376291_13g-satter.htm 0000895345-22-000734 005-83932 221291389 34 60048
2022-09-27 4 FORM 4 SUBMISSION 0001209191-22-051391 5749
2022-09-27 4 FORM 4 SUBMISSION 0001209191-22-051390 6245
2022-09-27 4 FORM 4 SUBMISSION 0001209191-22-051389 4757
2022-09-27 4 FORM 4 SUBMISSION 0001209191-22-051388 4780
2022-09-26 4 xslF345X03/ownership.xml 0000902664-22-004356 9931
2022-09-26 SC 13D/A AADI BIOSCIENCE, INC. 0000902664-22-004355 005-83932 221266815 34 76555
2022-09-22 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-22-249235 001-38560 221259667 34 651231 1 1
2022-08-10 10-Q 10-Q 0001628280-22-022208 001-38560 221151852 34 6656652 1 1
2022-08-10 8-K 8-K 2.02,9.01 0001193125-22-216844 001-38560 221150501 34 254433 1 1
2022-06-30 8-K 8-K 1.02 0001193125-22-185324 001-38560 221056302 34 148772 1 1
2022-06-17 8-K 8-K 5.07 0001193125-22-176646 001-38560 221025086 34 155322 1 1
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037893 7994
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037888 8027
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037883 8038
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037874 7970
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037866 8021
2022-06-17 4 FORM 4 SUBMISSION 0001209191-22-037859 12485
2022-05-12 10-Q 10-Q 0001564590-22-019856 001-38560 22917866 34 9929037 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001193125-22-148067 001-38560 22915698 34 256472 1 1
2022-04-26 DEFA14A DEFA14A 0001193125-22-119049 001-38560 22851919 34 120321
2022-04-26 DEF 14A DEF 14A 0001564590-22-015513 001-38560 22851785 34 1070842
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023352 8268
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023351 8158
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023350 8249
2022-04-05 4 FORM 4 SUBMISSION 0001209191-22-023349 8316
2022-03-22 4 FORM 4 SUBMISSION 0001209191-22-020582 9036
2022-03-21 424B5 424B5 0001193125-22-079762 333-255129 22754106 33 491795
2022-03-17 424B5 424B5 0001193125-22-078485 333-259785 22750011 33 490728
2022-03-17 8-K 8-K 1.01,9.01 0001193125-22-078484 001-38560 22750003 34 405462 1 1
2022-03-17 S-8 S-8 0001193125-22-078324 333-263639 22748765 33 77910
2022-03-17 10-K 10-K 0001564590-22-010721 001-38560 22746820 34 13767455 1 1
2022-03-17 8-K 8-K 2.02,9.01 0001193125-22-077792 001-38560 22746711 34 285365 1 1
2022-02-14 SC 13G SC 13G 0001104659-22-022801 005-83932 22631995 34 269455
2022-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-22-000440 005-83932 22623844 34 277161
2022-02-11 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-007078 005-83932 22622785 34 65551
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016347 005-83932 22606205 34 13187
2022-01-20 8-K 8-K 1.01 0001193125-22-012763 001-38560 22540530 34 146669 1 1
2021-11-29 3 FORM 3 SUBMISSION 0000899243-21-046210 7565
2021-11-23 8-K 8-K 8.01,9.01 0001193125-21-337294 001-38560 211434644 34 217032 1 1
2021-11-15 SC 13G/A SCHEDULE 13G/A 0001104659-21-139237 005-83932 211411422 34 80296
2021-11-12 SC 13D/A SC 13D/A 0001193125-21-328045 005-83932 211403286 34 30703
2021-11-10 10-Q 10-Q 0001564590-21-055958 001-38560 211394643 34 12681360 1 1
2021-11-10 8-K 8-K 2.02,9.01 0001193125-21-325243 001-38560 211394384 34 259180 1 1
2021-11-01 8-K 8-K 5.02,7.01,9.01 0001193125-21-315472 001-38560 211367585 34 182811 1 1
2021-10-25 4 FORM 4 SUBMISSION 0000899243-21-041483 6063
2021-10-25 3 FORM 3 SUBMISSION 0000899243-21-041480 6471
2021-10-04 424B3 424B3 0001193125-21-289952 333-259785 211300313 33 246984
2021-10-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-10-01 16:00:00 9999999995-21-003752 333-259785 211300890 33 1934
2021-09-30 CORRESP filename1.htm 0001193125-21-287949 7770
2021-09-29 UPLOAD filename1.pdf 0000000000-21-011837 40413
2021-09-24 S-8 S-8 0001193125-21-282449 333-259787 211278017 33 96625
2021-09-24 S-3 S-3 0001193125-21-282440 333-259785 211277978 33 341962
2021-09-24 8-K/A 8-K/A 9.01 0001193125-21-282412 001-38560 211277877 34 1184964 1 1
2021-09-22 4 FORM 4 SUBMISSION 0000899243-21-037065 6171
2021-09-22 3 FORM 3 SUBMISSION 0000899243-21-037063 5739
2021-09-20 8-K 8-K 5.02,7.01,9.01 0001193125-21-276826 001-38560 211262195 34 264367 1 1
2021-09-13 8-K 8-K 4.01,5.02,9.01 0001193125-21-270953 001-38560 211248701 34 182733 1 1
2021-09-10 4 FORM 4 SUBMISSION 0000899243-21-035568 6241
2021-09-10 4 FORM 4 SUBMISSION 0000899243-21-035558 6025
2021-09-10 3 FORM 3 SUBMISSION 0000899243-21-035554 5624
2021-09-10 D xslFormDX01/primary_doc.xml 06b 0001209191-21-055406 021-412879 211245700 33 15187
2021-09-10 D xslFormDX01/primary_doc.xml 06b 0001209191-21-055401 021-412878 211245695 33 13669
2021-09-08 SC 13D SC 13D 0001193125-21-267979 005-83932 211243019 34 47665
2021-09-07 SC 13G sc13g07422010_09072021.htm 0000921895-21-002248 005-83932 211240124 34 285226
2021-09-07 SC 13D AADI BIOSCIENCE, INC. 0001104659-21-113485 005-83932 211240117 34 68010
2021-09-03 8-K 8-K 1.01 0001193125-21-265609 001-38560 211237219 34 154027 1 1
2021-09-03 SC 13D/A AMENDMENT NO. 3 0000947871-21-000981 005-83932 211237127 34 88739
2021-09-02 SC 13G SCHEDULE 13G 0001213900-21-046399 005-83932 211233634 34 72450
2021-08-31 4 FORM 4 SUBMISSION 0000899243-21-034657 5914
2021-08-31 4 FORM 4 SUBMISSION 0000899243-21-034655 5854
2021-08-31 3 FORM 3 SUBMISSION 0000899243-21-034651 5732
2021-08-31 3 FORM 3 SUBMISSION 0000899243-21-034650 5617
2021-08-31 3 FORM 3 SUBMISSION 0000899243-21-034649 8511
2021-08-31 3 FORM 3 SUBMISSION 0000899243-21-034646 11156
2021-08-31 4/A FORM 4/A SUBMISSION 0000899243-21-034635 5931
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034553 9500
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034546 11970
2021-08-30 4 xslF345X03/ownership.xml 0000902664-21-004071 13266
2021-08-30 3 xslF345X02/ownership.xml 0000902664-21-004070 8735
2021-08-30 SC 13D/A AADI BIOSCIENCE, INC. 0000902664-21-004068 005-83932 211224624 34 83757
2021-08-27 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,9.01 0001193125-21-257910 001-38560 211213959 34 11999730 1 1
2021-08-23 8-K 8-K 1.01,9.01 0001193125-21-254142 001-38560 211197845 34 878057 1 1
2021-08-23 SC 13G AERPIO PHARMACEUTICALS, INC. 0001104659-21-108584 005-83932 211197337 34 76881
2021-08-18 8-K 8-K 5.07 0001193125-21-249389 001-38560 211184498 34 162805 1 1
2021-08-11 10-Q 10-Q 0001564590-21-043488 001-38560 211164133 34 6355774 1 1
2021-08-11 8-K 8-K 2.02,9.01 0001193125-21-243396 001-38560 211163686 34 88585
2021-07-26 8-K 8-K 5.07,7.01,9.01 0001193125-21-223693 001-38560 211112493 34 39780
2021-07-12 SC 13G AERPIO PHARMACEUTICALS, INC. 0001104659-21-091191 005-83932 211085843 34 85242
2021-07-08 DEFM14A DEFM14A 0001193125-21-210402 001-38560 211079095 34 7198113
2021-07-02 4 FORM 4 SUBMISSION 0000899243-21-027291 5013
2021-07-02 4 FORM 4 SUBMISSION 0000899243-21-027290 5003
2021-07-02 4 FORM 4 SUBMISSION 0000899243-21-027289 5044
2021-07-02 4 FORM 4 SUBMISSION 0000899243-21-027286 5059
2021-07-02 4 FORM 4 SUBMISSION 0000899243-21-027281 5043
2021-06-22 4 FORM 4 SUBMISSION 0000899243-21-025336 5273
2021-06-21 PREM14A PREM14A 0001193125-21-194158 001-38560 211027408 34 7240036
2021-06-09 DEFA14A DEFA14A 0001193125-21-186104 001-38560 211004089 34 126418
2021-06-09 DEF 14A DEF 14A 0001564590-21-032185 001-38560 211004086 34 1053061
2021-06-04 DEFA14A DEFA14A 0001193125-21-182391 001-38560 21995185 34 64615
2021-06-04 8-K 8-K 7.01,9.01 0001193125-21-182386 001-38560 21995182 34 52361
2021-06-04 SC 13D AERPIO PHARMACEUTICALS, INC. 0000902664-21-003006 005-83932 21994979 34 76069
2021-05-26 SC 13G SCHEDULE 13G 0000899140-21-000513 005-83932 21967199 34 44509
2021-05-20 DEFA14A DEFA14A 0001193125-21-167187 001-38560 21942344 34 62713
2021-05-20 8-K 8-K 7.01,9.01 0001193125-21-167180 001-38560 21942332 34 50249
2021-05-17 10-Q 10-Q 0001564590-21-028204 001-38560 21927887 34 4609735 1
2021-05-17 8-K 8-K 2.02,9.01 0001193125-21-162826 001-38560 21927694 34 76247
2021-05-17 8-K 8-K 1.01,3.02,5.01,5.02,5.03,7.01,9.01 0001193125-21-162770 001-38560 21927579 34 1372282
2021-05-17 DEFA14A 8-K 0001193125-21-162772 001-38560 21927569 34 1371730
2021-04-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-15 16:01:00 9999999995-21-001458 333-255129 21829993 33 1776
2021-04-13 CORRESP filename1.htm 0001193125-21-114919 7722
2021-04-12 UPLOAD filename1.pdf 0000000000-21-004405 40220
2021-04-08 S-3 S-3 0001564590-21-018182 333-255129 21815230 33 2090902
2021-04-02 4 FORM 4 SUBMISSION 0000899243-21-014676 5043
2021-04-02 4 FORM 4 SUBMISSION 0000899243-21-014675 5013
2021-04-02 4 FORM 4 SUBMISSION 0000899243-21-014674 5044
2021-04-02 4 FORM 4 SUBMISSION 0000899243-21-014672 5004
2021-04-02 4 FORM 4 SUBMISSION 0000899243-21-014673 5060
2021-04-01 8-K 8-K 5.02,9.01 0001193125-21-104183 001-38560 21799317 34 89195
2021-03-11 10-K 10-K 0001564590-21-012252 001-38560 21731918 34 7756752 1
2021-03-11 8-K 8-K 2.02,9.01 0001193125-21-077108 001-38560 21731906 34 86635
2021-03-05 8-K 8-K 8.01,9.01 0001193125-21-070454 001-38560 21716586 34 49147
2021-02-16 8-K 8-K 5.02,9.01 0001193125-21-044954 001-38560 21639148 34 65719
2021-02-10 SC 13G/A NONE 0001567619-21-002778 005-83932 21613446 34 82519
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017352 005-83932 21609908 34 13864
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004896 5328
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004893 5327
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004891 5342
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004890 5297
2021-02-01 8-K 8-K 2.05,5.02,9.01 0001193125-21-024764 001-38560 21577843 34 43251
2021-01-11 SC 13G SC 13G 0001193125-21-005470 005-83932 21518943 34 120424
2021-01-05 8-K 8-K 8.01,9.01 0001193125-21-001953 001-38560 21505544 34 41277
2020-12-11 8-K 8-K 8.01,9.01 0001193125-20-315989 001-38560 201384326 34 39960
2020-12-10 4 xslF345X03/ownership.xml 0000947871-20-000944 13926
2020-11-23 SC 13D/A SC 13D/A 0001193125-20-299536 005-83932 201333579 34 28739

Latest XBRL company facts

One latest value per concept from companyfacts (362 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 59.01M 2026-11-05 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
dei EntityPublicFloat Entity Public Float USD 64.90M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104158
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.59M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187149
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.96M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187149
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187149
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187149
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 18.86 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-187149
ffd NetFeeAmt NetFeeAmt USD 13,995.24 2026-05-28 S-3 2026-05-29 0001193125-26-248349
ffd TtlFeeAmt TtlFeeAmt USD 13,995.24 2026-05-28 S-3 2026-05-29 0001193125-26-248349
ffd TtlOfferingAmt TtlOfferingAmt USD 101.34M 2026-05-28 S-3 2026-05-29 0001193125-26-248349
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-28 S-3 2026-05-29 0001193125-26-248349
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-28 S-3 2026-05-29 0001193125-26-248349
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.20M 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 2.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 548,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 31,701 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 376,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -216,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 49,500 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 576.66M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 13.45M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.75M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 402,795 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 9,592 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 100,000 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -1.20M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001628280-23-017234
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 75,561 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD -3.14M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.06M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap Assets Assets USD 173.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AssetsCurrent Assets, Current USD 171.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 219,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 169.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212075
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 169.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 68.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -14.46M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030747
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 169.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 68.97M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 31.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 7.29 2019-10-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 40,000 2019-10-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 29,167 2023-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 59.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 59.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CommonStockValue Common Stock, Value, Issued USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -60.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 18.67M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021632
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 74.70M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 9.50M 2021-08-26 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 1.10M 2020-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 9.03M 2020-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CostsAndExpenses Costs and Expenses USD 64.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 9,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0001628280-22-022208
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 698,018 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 4.8 2021-05-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.06 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 5,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax USD -8,000 2024-03-31 2024 Q1 10-Q 2024-05-08 0001628280-24-021657
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 96.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 115,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 31,042 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013535
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 44.69M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.34M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsInvestmentInSubsidiaries Deferred Tax Assets, Investment in Subsidiaries USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 115,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 26.50M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.21M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.11M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 428,125 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 107,525 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 44.58M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 115,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 17,425 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 20,000 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap Depreciation Depreciation USD 2,400 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 79,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 205,041 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001427
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 258,000 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 5.76M 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.66 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 3.304 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.215 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent pure -0.536 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.022 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.107 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.071 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 9.90M 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 87,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001628280-22-029228
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 2.45M 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 273,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 205,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 273,000 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 273,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 273,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 273,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap FiniteLivedIntangibleAssetsFairValueDisclosure Finite-lived Intangible Assets, Fair Value Disclosure USD 3.90M 2021-08-26 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 3.81M 2022-09-30 2022 Q3 10-Q 2022-11-09 0001628280-22-029228
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2022-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -93,285 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.51M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037905
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -60.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncomeTaxesPaid Income Taxes Paid USD 9,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001628280-22-029228
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037905
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018033
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -68.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -4.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -6,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 925,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 100 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 2.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 600 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD -817,121 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052756
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -8.38M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -7,371 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001213900-16-018356
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4,375 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 18.67M 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030747
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -20,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -20,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 9,942 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 1,500 2007-11-16 2012-03-31 2012 Q1 10-Q 2012-05-15 0001144204-12-029112
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -1.03M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -439,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 394,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001628280-24-045698
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -2,500 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001213900-16-012024
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 0 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap InterestExpense Interest Expense USD 58,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001628280-24-021657
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 5,707 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InterestPayableCurrent Interest Payable, Current USD 483,442 2016-12-31 2017 FY 10-K 2018-03-15 0001564590-18-005868
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InventoryNet Inventory, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.077 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 228,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 110,000 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 140,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 109,000 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 109,000 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 280,000 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 54,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 34,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap Liabilities Liabilities USD 10.53M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 173.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LiabilitiesCurrent Liabilities, Current USD 10.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 81.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 21,992 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013535
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 6.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -8,498 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013535
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -56.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -6.51M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001564590-18-013535
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -60.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -60.51M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -60.51M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.52M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 170,000 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingExpenses Operating Expenses USD 112.34M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -64.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeaseCost Operating Lease, Cost USD 113,429 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 218,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 130,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 88,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 212,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 344,779 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028092
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 257,050 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 239,781 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 31,653 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028092
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 183,222 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.133 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 42,400 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OtherAssetsCurrent Other Assets, Current USD 578,461 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -15,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001628280-25-023932
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -99,000 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0001628280-23-037905
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -336,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 99,000 2020-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 4.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0001628280-22-022208
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 204,929 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 264,247 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-15 0001564590-18-005868
us-gaap PaymentsOfDividends Payments of Dividends USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 120,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 5.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 105.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 145.19M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PreferredStockRedemptionDiscount Preferred Stock Redemption Discount USD 224,224 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-13 0001564590-17-023441
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 510,177 2020-12-31 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 297,354 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 25.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 10,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 15.00M 2020-05-01 2020-05-31 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 111.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 120,000 2007-11-16 2013-06-30 2013 Q2 10-Q 2013-08-14 0001213900-13-004342
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 10,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-07 0001213900-17-002066
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 56,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 402,346 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-052756
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 379,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 3,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units Property 3 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap ProvisionForLoanAndLeaseLosses Provision for Loan and Lease Losses USD 66,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 2.70M 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 4.40M 2024-09-30 2024 Q3 10-Q 2024-11-06 0001628280-24-045698
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 224,224 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-15 0001564590-18-005868
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 73.76M 2016-12-31 2017 FY 10-K 2018-03-15 0001564590-18-005868
us-gaap RelatedPartyCosts Related Party Costs USD 578,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 1.40M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0001564590-22-010721
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 10,000 2007-11-17 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001427
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 10,000 2007-11-16 2013-03-31 2013 Q1 10-Q 2013-05-15 0001144204-13-029407
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 48.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 7 2021-01-01 2021-01-31 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.58 2021-01-01 2021-01-31 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap RestructuringCosts Restructuring Costs USD 1.24M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -413.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 227,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 16.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap SeveranceCosts1 Severance Costs USD 1.20M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 300,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.847 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.821 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.791 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.049 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 41,394 2021-03-31 2021 Q1 10-Q 2021-05-17 0001564590-21-028204
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.71 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 48,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 518,706 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 796,199 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 10.9 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-268895
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 41,539 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.85 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 1.11 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-011174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 10.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 12.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.44 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 4.47M 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 419,036 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 8.26 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 10.27M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 12.15M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.44 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.69 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 300,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 83,410 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001564590-21-043488
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 15.18 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 9.76 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap SharesOutstanding Shares, Outstanding shares 8.10M 2021-08-26 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap ShortTermInvestments Short-term Investments USD 100.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 163.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.067 2021-08-26 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.56M 2021-08-26 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 24,286 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-29 0001628280-23-009583
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 28,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD -152,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 56,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 943,297 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006602
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 73.76M 2016-12-31 2017 Q2 10-Q 2017-08-10 0001564590-17-017234
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 207,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 235,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010901
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued Unrecognized Tax Benefits, Income Tax Penalties Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012252
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 290,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2024-12-31 2024 FY 10-K 2025-03-28 0001628280-25-015269
us-gaap UnsecuredDebt Unsecured Debt USD 15,000 2014-09-30 2014 Q3 10-Q 2014-11-14 0001213900-14-008152
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -77.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104158
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 82.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 20.91M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019856
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 82.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453576

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →